Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1918 Nov 30;28(6):779–790. doi: 10.1084/jem.28.6.779

STANDARDIZATION OF ANTIMENINGOCOCCIC SERUM

Harold L Amoss 1, Penelope Marsh 1
PMCID: PMC2126311  PMID: 19868294

Abstract

Experiments were made for the purpose of testing the reaction of protection against infection as a measure of potency of antimeningococcic serum. The results of the experiments were extremely variable and bore no relation to the quality of the sera as determined by the period of immunization of the horses from which they were obtained, or the indications of efficiency based upon their employment in human cases of epidemic meningitis. The results also failed entirely to conform to the agglutination titer of the sera tested and to be affected by the different type forms of the meningococci. We regard the protective power for laboratory animals of the antimeningococcic serum as an unsuitable index of its value in human medicine and as inferior to the agglutination titer as a standard of potency.

Full Text

The Full Text of this article is available as a PDF (506.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amoss H. L., Wollstein M. A METHOD FOR THE RAPID PREPARATION OF ANTIMENINGITIS SERUM. J Exp Med. 1916 Mar 1;23(3):403–417. doi: 10.1084/jem.23.3.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Flexner S., Amoss H. L. CHEMICAL VERSUS SERUM TREATMENT OF EPIDEMIC MENINGITIS. J Exp Med. 1916 May 1;23(5):683–701. doi: 10.1084/jem.23.5.683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Flexner S. CONCERNING A SERUM-THERAPY FOR EXPERIMENTAL INFECTION WITH DIPLOCOCCUS INTRACELLULARIS. J Exp Med. 1907 Mar 14;9(2):168–185. doi: 10.1084/jem.9.2.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Flexner S. CONCERNING A SERUM-THERAPY FOR EXPERIMENTAL INFECTION WITH DIPLOCOCCUS INTRACELLULARIS. J Exp Med. 1907 Mar 14;9(2):168–185. doi: 10.1084/jem.9.2.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Flexner S. CONCERNING A SERUM-THERAPY FOR EXPERIMENTAL INFECTION WITH DIPLOCOCCUS INTRACELLULARIS. J Exp Med. 1907 Mar 14;9(2):168–185. doi: 10.1084/jem.9.2.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Flexner S. CONCERNING A SERUM-THERAPY FOR EXPERIMENTAL INFECTION WITH DIPLOCOCCUS INTRACELLULARIS. J Exp Med. 1907 Mar 14;9(2):168–185. doi: 10.1084/jem.9.2.168. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Flexner S. CONTRIBUTIONS TO THE BIOLOGY OF DIPLOCOCCUS INTRACELLULARIS. J Exp Med. 1907 Mar 14;9(2):105–141. doi: 10.1084/jem.9.2.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jobling J. W. STANDARDIZATION OF THE ANTIMENINGITIS SERUM. J Exp Med. 1909 Jul 17;11(4):614–621. doi: 10.1084/jem.11.4.614. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES